Agonist thụ thể dopamine: Các cơ chế cơ sở đối với tính chọn lọc tự thụ thể II. Các cân nhắc lý thuyết

Arbuthnott, G. W.: Studies on the interaction between the substantia nigra and the neostriatum. In: Adv. Biochem. Psychopharmacol., Vol. 19 (Roberts, P. J., Woodruff, G. N., Iversen, L. L., eds.). New York: Raven Press. 1978. Ariens, E. J., Simonis, A. M., Van Rossum, J. M.: Drug-receptor interaction: Interaction of one or more drugs with one receptor system. In: Molecular Pharmacology (Ariens, E. J., ed.), pp. 119–286 (section IIA). London: Academic Press. 1964. Arnt, J., Hyttel, J.: Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions. Eur. J. Pharmacol.102, 349–354 (1984 b). Arnt, J., BØgesØ, K. P., Hyttel, J., Larnen, J. -J., Svendsen, O.: Effects of S-(+)-3-phenethyl-PP, a putative dopamine autoreceptor agonist with greater autoreceptor selectivity than 3-PPP enantiomers. Eur. J. Pharmacol.102, 91–99 (1984). Bannon, M. J., Bunney, E. B., Zigun, J. R., Skirboll, L. R., Roth, R. H.: Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol. Naunyn-Schmiedeberg's Arch. Pharmacol.312, 161–165 (1980). Becker, J. B.: Simultaneous release of endogenous and3H-dopamine. Soc. Neurosci. Abstr.10, 362 (1984). Bindra, D. A.: How adaptive behaviour is produced: a perceptual-motivational alternative to response-reinforcement. Behav. Brain Sci.1, 41–92 (1978). Bolam, J. P., Powell, J. F., Totterdell, S., Smith, A. D.: The proportion of neurons in the rat neostriatum that project ot the substantia nigra demonstrated using horseradish peroxidase conjugated with wheatgerm agglutinin. Brain Res.220, 339–343 (1981). Bozarth, M. A.: Opiate reward mechanisms mapped by intracranial self administration. In: Neurobiology of Opiate Reward Mechanisms (Smith, J. E., Lane, J. D., eds.). New York: Raven Press. 1981. Bürki, H. R., Eichenberger, E., Sayers, A. C., White, T. C.: Clozapine and the dopamine hypothesis of schizophrenia, a critical appraisal. Pharmakopsychiat.8, 115–121 (1975). Cheramy, A., Leviel, V., Glowinski, J.: Dendritic release of dopamine in the substantia nigra. Nature (Lond.)289, 537–542 (1981). Clark, D., Hjorth, S., Carlsson, A.: Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivity. I. Review of the evidence. J. Neural Transm.62, 1–52 (1985 b). Corsini, G. U., Pitzalis, G. F., Bernardi, F., Bocchetta, A., Del Zompo, M.: The use of dopamine agonists in the treatment of schizophrenia. Neuropharmacol.20, 1309–1313 (1981). Costall, B., Fortune, B. H., Hui, S. -C., Naylor, R. J.: Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic-receptors? Eur. J. Pharmacol.63, 347–358 (1980). Creese, I., Iversen, S. D.: The role of forebrain dopamine systems in amphetamine-induced stereotyped behaviour in the rat. Psychopharmacol.39, 345–357 (1974). Creese, I., Burt, D. R., Snyder, S. H.: Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science197, 596–598 (1977). Creese, I., Leff, S. E., Sibley, D. R., Hamblin, M. W.: Radioligand binding studies of agonist interactions with dopamine receptors. In: Dopamine Receptor Agonists (Poste, G., Crooke, S. T., eds.). New York: Plenum Press. 1984. Crow, T. J., Cross, A. J., Johnson, J. A., Johnstone, E. C., Joseph, M. H., Owen, F., Owens, D. G. C., Poulter, M.: Catecholamines and schizophrenia. In: Neurology and Neurobiology, Vol. 8 C: Catecholamines: Neuropharmacology and Central Nervous System—Therapeutic Aspects (Usdin, E., Carlsson, A., Dahlström, A., Engel, J., eds.), pp. 11–20. New York: Alan R. Liss. 1984. Deniker, P.: Discovery of the clinical use of neuroleptics. In: Discoveries in pharmacology, Vol. 1, Psycho- and Neuro-Pharmacology (Parnham, M. J., Bruinvels, J., eds.), pp. 163–180. Amsterdam: Elsevier. 1983. Domesick, V. B.: The anatomical basis for feedback and feedforward in the striatonigral system. In: Apomorphine and Other dopaminomimetics, Vol. 1: Basic Pharmacology (Gessa, G. L., Corsini, G. U., eds.), pp. 27–39. New York: Raven Press. 1981. Dunstan, R., Broekkamp, C. L., Lloyd, K. G.: Involvement of caudate nucleus, amygdala or reticular formation in neuroleptic and narcotic catalepsy. Pharmacol. Biochem. Behav.14, 169–174 (1981). Eriksson, E., Clark, D., Svensson, K.: The putative dopamine autoreceptor agonist B-HT 920 decreases dopamine cell firing and prolactin release in rat. Life Sci.36, 1819–1827 (1985). Fenton, H. M., Leszczak, E., Gerhardt, S., Liebman, J. M.: Evidence for hetero-genous rotational responsiveness to apomorphine, 3-PPP and SKF 38393 in 6-hydroxydopamine-denervated rats. Eur. J. Pharmacol.106, 363–372 (1984). Feuerstein, C., Demenge, P., Caron, P., Barrette, G., Guerin, B., Mouchet, P.: Supersensitivity time course of dopamine antagonist binding after nigrostriatal denervation: evidence for early and drastic changes in rat corpus striatum. Brain Res.226, 221–234 (1981). Fielding, S., Lal, H.: Behavioural actions of neuroleptics. In: Handbook of Psychopharmacology, Vol. 10 (Iversen, L. L., Iversen, S. D., Snyder, S. H., eds.), pp. 91–128. New York: Plenum Press. 1978. O'Neill, R. D., Fillenz, M.: Detection of homovanillic acidin vivo using microcomputer-controlled voltammetry: simultaneous monitoring of rat motor activity and striatal dopamine release. Neurosci.14, 753–763 (1985). Fray, P. J., Sahakian, B. J., Robbins, T. W., Koob, G. F., Iversen, S. D.: An observational method for quantifying the behavioural effects of dopamine agonists: Contrasting effects of d-amphetamine and apomorphine. Psychopharmacol.69, 253–259 (1980). Groves, P. M.: A theory of the functional organization of the neostriatum and the neostriatal control of voluntary movement. Brain Res. Rev.5, 109–132 (1983). Gundlach, A. L., Krstich, M., Beart, P. M.: Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates. Brain Res.278, 155–163 (1983). Heikkila, R. E., Shapiro, B. S., Duvoisin, R. C.: The relationship between loss of dopamine nerve terminals, striatal3H-spiroperidol binding and rotational behavior in unilaterally 6-hydroxydopamine-lesioned rats. Brain Res.211, 285–292 (1981). Helmreich, I., Reimann, W., Hertting, G., Starke, K.: Are presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in the rabbit caudate nucleus pharmacologically different? Neurosci.7, 1559–1566 (1982). Hoebel, B. G., Hernandez, L., McLean, S., Stanley, B. G., Aulissi, E. F., Glimcher, P., Margolin, D.: Catecholamines, enkephalin and neurotensin in feeding and reward. In: The Neural Basis of Feeding and Reward (Hoebel, B. G., Novin, D., eds.), pp. 465–478. Brunswick, ME: Haer Institute. 1981. Iversen, S. D.: Brain dopamine systems and behaviour. In: Handbook of Psychopharmacology, Vol. 8 (Iversen, L. L., Iversen, S. D., Snyder, S. H., eds.), pp. 333–384. New York: Plenum Press. 1977. Janssen, P. A. J., Van Bever, W. F. M.: Structure-activity relationships of the butyrophenones and diphenylbutyl-piperidines. In: Handbook of Psychopharmacology, Vol. 10: Neuroleptics and Schizophrenia (Iversen, L. L., Iversen, S. D., Snyder, S. H., eds.), pp. 1–35. New York: Plenum Press. 1978. Kehr, W.: Temporal changes in catecholamines synthesis of rat forebrain structures after axotomy. J. Neural Transm.35, 307–317 (1974). Kelly, P. H., Seviour, P. W., Iversen, S. D.: Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res.94, 507–522 (1975). Kenakin, T. P.: The classification of drugs and drug receptors in isolated tissues. Pharmacol. Rev.36, 165–222 (1984). Koffer, K. B., Berney, S., Hornykiewicz, O.: The role of the corpus striatum in neuroleptic- and narcotic-induced catalepsy. Eur. J. Pharmacol.47, 81–86 (1978). Koob, G. F., Simon, H., Herman, J. P., Le Moal, M.: Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems. Brain Res.303, 319–329 (1984). Lai, H., Carino, M. A., Sperry, R., Horita, A.: Effects of thioridazine on apomorphine-elicited Stereotypic behavior and motor activity. Pharmacol. Biochem. Behav.13, 397–401 (1980). Leysen, J. E.: Multiple dopamine receptors: Relevance ofin vitro binding data of subclassification of binding sites. In: Neurology and Neurobiology, Vol. 8A: Catecholamines: Basic and Peripheral Mechanisms (Usdin, E., Carlsson, A., Dablström, A., Engel, J., eds.), pp. 225–235. New York: Alan R. Liss. 1984. Liebman, J., Neale, R.: Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects. Psychopharmacol.68, 25–29 (1980). Maeda, H., Mogenson, G. J.: Effects of peripheral stimulation on the activity of neurons in the ventral tegmental area. Brain Res. Bull.8, 7–14 (1982). Mogenson, G. J., Jones, D. L., Yim, C. Y.: From motivation to activation: functional interface between the limbic system and the motor system. Progr. Neurobiol.14, 69–97 (1980). Molloy, A. G., Waddington, J. L.: Dopaminergic behaviour stereospecifically promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390. Psychopharmacol.82, 409–410 (1984). Muller, P. E., Panerai, A. E., Cocchi, D., Mantegazza, P.: Endocrine profile of ergot alkaloids. Life Sci.21, 1545–1558 (1977). Nissbrandt, H., Pileblad, E., Carlsson, A.: Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra. Manuscript submitted (1985). Neve, K. A., Marshall, J. F.: The effects of denervation and chronic haloperidol treatment on neostriatal dopamine receptor sensitivity are not additive in the rat. Neurosci. Letters46, 77–83 (1984). Petty, F., Mott, J., Sherman, A. O.: Potential locus and mechanism of blockade of conditioned avoidance responding by neuroleptics. Neuropharmacol.23, 73–78 (1984). Phillips, A. G., Maccrea, J., Fibiger, H. C.: Separate roles for nucleus accumbens and caudate in acquisition and performance of avoidance behaviour. Soc. Neurosci. Abstr.9, 829 (abstr. no 240.3) (1983). Porsolt, R. D., Jalfre, M.: Neuroleptic-induced acute dyskinesias in Rhesus monkeys. Psychopharmacol.75, 16–21 (1981). Posluns, D.: An analysis of chlorpromazine-induced suppression of the avoidance response. Psychopharmacol.3, 361–373 (1962). Reches, A., Wagner, R. H., Jackson, V., Yablonskaya-Alter, E., Fahn, S.: Dopamine receptors in the denervated striatum: Further supersensitivity by chronic haloperidol treatment. Brain Res.275, 183–185 (1983). Rollema, H., Mastebroek, D.: Catecholamine formation from 3-PPPin vitro andin vivo. Presented at the VIIIth Symp. on Med. Chem., Aug. 27–31, Uppsala, Sweden, Proceedings: in press (1984). Roth, R. H., Galloway, M. P., Tam, S.-Y., Ono, N., Wolf, M. E.: Dopamine auto-receptors: studies of their distribution and mode of action. Presented at the IUPHAR satellite symposium “Dopamine 84”, Southampton, U.K., August 5–8, 1984. Proceedings: in press (1984). Scatton, B.: Neurochemistry of monoaminergic neurons in Parkinson's disease. In: Neurology and Neurobiology, Vol. 8 C: Catecholamines: Neuropharmacology and Central Nervous System—Therapeutic Aspects (Usdin, E., Carlsson, A., Dahlström, A., Engel, J., eds.), pp. 43–52. New York: Alan R. Liss. 1984. Schultz, W.: Depletion of dopamine in the striatum as an experimental model of Parkinsonism: direct effects and adaptive mechanisms. Progr. Neurobiol.18, 121–166 (1982). Seyfried, C. A., Fuxe, K., Wolf, H. -P., Agnati, L.: Neurochemical and functional studies with EMD 23448, a novel dopamine agonist. Acta Pharmaceut. Suec, suppl.,2, 243–247 (1983). Sherman, A. D., Petty, F.: Locus of action of antipsychotic drugs. Soc. Neurosci. Abstr.7, 203 (1981). Sibley, D. R., Creese, L.: Dopamine receptor binding in bovine intermediate lobe pituitary membranes. Endocrinol.107, 1405–1409 (1980). Sibley, D. R., Leff, S. E., Creese, I.: Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors. Life Sci.31, 637–645 (1982 b). Somogyi, P., Bolam, J. P., Smith, A. D.: Monosynaptic cortical input and local axon collaterals of identified striatonigral neurons. A light and electron microscopic study using the Golgi-Peroxidase transport degeneration procedure. J. Comp. Neurol.195, 567–584 (1981). Starke, K.: Functionalin vitro comparison of striatal pre- and postsynaptic dopamine receptors. In: Neurology and Neurobiology, Vol. 8 B: Catecholamines: Neuropharmacology and Central Nervous System— Theoretical Aspects (Usdin, E., Carlsson, A., Dahlström, A., Engel, J., eds.), pp. 5–11. New York: Alan R. Liss. 1984. Staunton, D. A., Wolfe, B. B., Groves, P. M., Molinoff, P. B.: Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior. Brain Res.211, 315–327 (1981). Staunton, D. A., Magistretti, P. J., Koob, G. F., Shoemaker, W. J., Bloom, F. E.: Dopaminergic supersensitivity induced by denervation and chronic receptor blockade is additive. Nature299, 72–74 (1982). Wang, R. Y.: Dopaminergic neurons in the rat ventral tegmental area. I. Identification and characterization. Brain Res. Rev.3, 123–140 (1981 a). Wang, R. Y.: Dopaminergic neurons in the rat ventral tegmental area. II. Evidence for autoregulation. Brain Res. Rev.3, 141–153 (1981 b). White, F. J., Wang, R. Y.: Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies. J. Pharmacol. Exp. Therap.231, 275–280 (1984 b). Wikström, H., Sanchez, D., Lindberg, P., Arvidsson, L. -E., Johansson, A., Thorberg, S. -O., Nilsson, J. L. G., Svensson, K., Hjorth, S., Clark, D., Carlsson, A.: Resolved 3-(3-hydroxyphenyl)-N-n-propylpiperidine and its analogues: Central dopamine receptor activity. J. Med. Chem.27, 1030–1036 (1984). Willner, P.: Dopamine and depression. A review of recent evidence. II. Theoretical approaches. Brain Res. Rev.6, 225–236 (1983). Wise, R. A.: Catecholamine theories of reward: a critical review. Brain Res.152, 215–247 (1978). Wise, R. A.: Neuroleptics and operant behaviour: the anhedonia hypothesis. Behav. Brain Sci.5, 39–87 (1982).